AstraZeneca's second-quarter core earnings per share were $2.63, compared to a market estimate of $2.48. Second-quarter core operating profit was $5.16 billion, versus the market estimate of $5.12 billion. Second-quarter core gross profit reached $12.86 billion, while the market estimate was $12.73 billion. Second-quarter revenue was $15.38 billion, compared to a market estimate of $15.42 billion.

AstraZeneca's second-quarter core earnings per share were $2.63, compared to a market estimate of $2.48. Second-quarter core operating profit was $5.16 billion, versus the market estimate of $5.12 billion. Second-quarter core gross profit reached $12.86 billion, while the market estimate was $12.73 billion. Second-quarter revenue was $15.38 billion, compared to a market estimate of $15.42 billion.

智通财经2026/07/27 06:16

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AstraZeneca's core earnings per share for the second quarter were $2.63, with the market expecting $2.48. Second quarter core operating profit was $5.16 billion, with the market expecting $5.12 billion. Second quarter core gross profit was $12.86 billion, with the market expecting $12.73 billion. Second quarter revenue was $15.38 billion, with the market expecting $15.42 billion.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

You may also like

Crypto prices